Diovan
Links shared publicly online about this topic
Diovan HCT Side Effects
drugs.com — “Comprehensive and accurate Diovan HCT side effects information for consumers and healthcare professionals.” View full resource at drugs.com
Most Recently Shared on February 19, 2010 at 7:26 pm By:
Renal insufficiency as a side effect of Diovan - Get more information. http://bit.ly/chXaW6
iGuard.org - Diovan Drug Interactions, Diovan Side Effects and Diovan Patient Reviews
iguard.org — “iGuard.org - Diovan Drug Interactions, Diovan Side Effects and Diovan Patient Reviews” View full resource at iguard.org
Most Recently Shared on June 23, 2010 at 12:17 pm By:
MediGuard.org Health Organization
Approx 5% of #diovan users experiencing fatigue: http://tinyurl.com/ye8e4ak
iGuard.org - Diovan Drug Interactions, Diovan Side Effects and Diovan Patient Reviews
iguard.org — “iGuard.org - Diovan Drug Interactions, Diovan Side Effects and Diovan Patient Reviews” View full resource at iguard.org
Most Recently Shared on August 11, 2010 at 3:17 pm By:
MediGuard.org Health Organization
#diovan risks versus benefits: 87% of users think its worth it http://tinyurl.com/ye8e4ak
Medication | Health Articles | Diovan Drug Information For Blood Pressure Patients: Side effects
worldwidehealth.com — “Medication | Health Articles | Diovan Drug Information For Blood Pressure Patients: Side effects” View full resource at worldwidehealth.com
Most Recently Shared on October 21, 2010 at 3:20 am By:
Diovan Drug Information For Blood Pressure Patients http://t.co/ETwiwKv
Alcohol abuse (Alcoholism) in Diovan hct, reported by 3 people - eHealthMe.com
ehealthme.com — “Real world drug outcomes: Alcohol abuse in Diovan hct from a study of 3 people. Find out who take the drug, for how long, and how severe is Alcohol abuse” View full resource at ehealthme.com
Most Recently Shared on February 28, 2011 at 10:12 am By:
Peter H Brown Doctor and Psychologist
Alcohol abuseAlcoholism in Diovan hct reported by 3 people ... http://bit.ly/gAqGa8
Novartis gains new indication for Diovan* for the treatment of children and adolescents with high blood pressure in the EU
novartis.com — “Novartis gains new indication for Diovan* for the treatment of children and adolescents with high blood pressure in the EU” View full resource at novartis.com
Most Recently Shared on April 23, 2010 at 7:16 am By:
New indication brings #1 selling high blood pressure medicine to EU patients aged 6-18 years: http://bit.ly/dCU5hk
Jimenez aims to keep off-patent Diovan in blockbuster territory - FiercePharma
fiercepharma.com — “Yesterday, we got some hints about Pfizer's post-patent strategy for Lipitor. Novartis ($NVS) CEO Joe Jimenez (photo) is also thinking patents. He's now talking about his company's post-patent plans Read more...” View full resource at fiercepharma.com
Most Recently Shared on August 5, 2011 at 4:24 pm By:
Today, it's the Novartis post-patent strategy for Diovan. http://bit.ly/nCUdXG
Diovan satisfaction and usage data | Monitoring more than 24,000 patients | Drug safety information | MediGuard
mediguard.org — “Diovan satisfaction and usage data | Monitoring more than 24,000 patients | Drug safety information | MediGuard” View full resource at mediguard.org
Most Recently Shared on June 24, 2011 at 3:17 pm By:
MediGuard.org Health Organization
94% of patients taking #diovan use it for High Blood Pressure ... http://tinyurl.com/4dyjqwh
Novartis Diovan HCT Shellpak Wins the Healthcare Compliance Packaging Council--™s Compliance Package of the Year Award | Business Wire
businesswire.com — “Compliance Package of the Year honor given in recognition of package created for Novartis Diovan HCT, which is fulfilled by Anderson using MWV’s” View full resource at businesswire.com
Most Recently Shared on May 12, 2011 at 2:59 pm By:
Congrats to @MWVPackaging for winning Compliance Package of the Year! http://bit.ly/is5vkW #ptsafety #compliance #pharmacy #pharmacists
PharmaLive: Novartis to Restructure US Business to Strengthen Competitive Position in Light of Loss of Diovan Patent and Announces Charge for Rasilez/Tekturna
pharmalive.com — “PharmaLive: Novartis to Restructure US Business to Strengthen Competitive Position in Light of Loss of Diovan Patent and Announces Charge for Rasilez/Tekturna” View full resource at pharmalive.com
Most Recently Shared on January 13, 2012 at 3:00 pm By:
PharmaLive Health News and Pharma
Novartis to Restructure US Business: http://t.co/7jAxEjgQ #pharma
FACTBOX-World's top-selling drugs in 2014 vs 2010 | Reuters
reuters.com — “April 13 (Reuters) - Roche's cancer drug Avastin isexpected to be the world's biggest-selling drug in 2014, astoday's two top blockbusters -- Lipitor and Plavix -- losepatent protection” View full resource at reuters.com
Most Recently Shared on April 13, 2010 at 1:30 pm By:
World's top-selling drugs in 2014 vs 2010 - Lipitor, Plavix and Diovan fall out of Top 10. http://is.gd/bqXj2
Search For New Diabetes And Heart Disease Treatments Unresolved
medicalnewstoday.com — “Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with” View full resource at medicalnewstoday.com
Most Recently Shared on March 17, 2010 at 5:13 pm By:
Search For New Diabetes And Heart Disease Treatments Unresolved http://mnt.to/3z3j #diabetes
Valsartan cuts stroke in high-risk hypertensives in KYOTO HEART trial
theheart.org — “Despite showing an impressive 45% reduction in stroke with valsartan add-on therapy compared with non-ARB add-on treatment in high-risk hypertensive patients in Japan, the findings of the KYOTO HEART study are not strong enough to support ARB use as first-line therapy in Western populations, say expert observers.” View full resource at theheart.org
Most Recently Shared on September 1, 2009 at 3:26 pm By:
heartwire: KYOTO HEART study not quite sufficient to extend the role of ARBs to first-line therapy http://bit.ly/uasES #ESC09
New Combo Drug May Cut Blood Pressure
webmd.com — “By itself, Novartis's new blood pressure drug doesn't do a lot. But combined with the older drug Diovan, it boosts hypertension control better than either drug alone.” View full resource at webmd.com
Most Recently Shared on March 16, 2010 at 9:47 pm By:
New Combo Drug May Cut Blood Pressure: By itself, Novartis's new blood pressure drug doesn't do a lot. But combine... http://bit.ly/bDQe3W
Medical News: ACC: Outcomes Similar With ARBs, Ca Channel Blockers - in Meeting Coverage, ACC from MedPage Today
medpagetoday.com — “NEW ORLEANS -- For patients who have hypertension and either diabetes or impaired glucose tolerance, clinical outcomes were similar whether they took valsartan (Diovan), an angiotensin II receptor blo” View full resource at medpagetoday.com
Most Recently Shared on April 8, 2011 at 2:13 pm By:
Patricia Grace Eldercare Expert
ACC: Outcomes Similar With ARBs, Ca Channel Blockers (CME/CE): NEW ORLEANS (MedPage Today) -- For patients who h... http://bit.ly/ia4YEU
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
Advertisement
